Medical Sciences Divisional Office
University of Oxford
Level 3, John Radcliffe Hospital
Oxford OX3 9DU
Head of Medical Sciences Division
The Head of Division is responsible for maintaining and further developing the international reputation of Medical Sciences in both research and teaching. He provides vision and leadership across all aspects of the Division's activities including divisional research strategy, educational policy and standards, the recruitment and retention of outstanding academics, relationships with external funding agencies, interactions with local NHS Foundation Trusts, fundraising, improving diversity and equality, and the use of resources. He works closely with the heads of the 16 departments within the Division and the other University academic divisions to foster strong interdisciplinary links across the spectrum of academic activity and with the colleges to help maintain excellence in teaching for undergraduate and graduate courses.
The Head of Division is a member of University Council and its major committees, which are responsible for determining overall university strategy.
Prior to being appointed as the Head of the Medical Sciences Division, Professor Screaton was Dean of the Faculty of Medicine, Imperial College.
Convalescent plasma therapy for the treatment of patients with COVID-19: Assessment of methods available for antibody detection and their correlation with neutralising antibody levels.
Harvala H. et al, (2020), Transfus Med
Community prevalence of SARS-CoV-2 in England from
April to November, 2020: results from the ONS Coronavirus
POUWELS K. et al, (2020), Lancet Public Health
Antibodies targeting epitopes on the cell-surface form of NS1 protect against Zika virus infection during pregnancy.
Wessel AW. et al, (2020), Nat Commun, 11
SARS-CoV-2 RNA detected in blood products from patients with COVID-19 is not associated with infectious virus
Andersson M. et al, (2020), Wellcome Open Research, 5, 181 - 181
SARS-CoV-2 antibody prevalence, titres and neutralising activity in an antenatal cohort, United Kingdom, 14 April to 15 June 2020.
Lumley SF. et al, (2020), Euro Surveill, 25